CMV and blood transfusions

Among the human herpesviruses, cytomegalovirus (CMV) is the only one that has assumed significant importance in blood transfusion. Transfusion transmission of CMV (TT‐CMV) to seronegative immunocompromised patients can lead to lethal CMV disease. Studies over the past 30 years have demonstrated that...

Full description

Saved in:
Bibliographic Details
Published in:Reviews in medical virology 2002-07, Vol.12 (4), p.211-219
Main Author: Roback, John D.
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Child
Child, Preschool
Cytomegalovirus - isolation & purification
Cytomegalovirus Infections - diagnosis
Cytomegalovirus Infections - prevention & control
Cytomegalovirus Infections - transmission
Disinfection - methods
DNA, Viral - analysis
Female
Human viral diseases
Humans
Infant, Newborn
Infectious diseases
Medical sciences
Miscellaneous
Polymerase Chain Reaction
Pregnancy
Risk Factors
Transfusion Reaction
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3
cites cdi_FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3
container_end_page 219
container_issue 4
container_start_page 211
container_title Reviews in medical virology
container_volume 12
creator Roback, John D.
description Among the human herpesviruses, cytomegalovirus (CMV) is the only one that has assumed significant importance in blood transfusion. Transfusion transmission of CMV (TT‐CMV) to seronegative immunocompromised patients can lead to lethal CMV disease. Studies over the past 30 years have demonstrated that monocytes latently infected with CMV represent the primary vector for TT‐CMV, and that TT‐CMV can be largely abrogated by transfusing at‐risk patients with either seronegative units or blood filtered to remove white blood cells. However, the small number of cases of breakthrough TT‐CMV that follow transfusion of either seronegative or filtered blood still produce morbidity and mortality. These circumstances have motivated ongoing efforts to provide improved protection from TT‐CMV, including the use of CMV DNA amplification for blood screening, and pathogen inactivation to sterilise all blood components prior to transfusion. Copyright © 2002 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/rmv.353
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71925899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18462904</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3</originalsourceid><addsrcrecordid>eNqF0MlLAzEUBvAgiq0L3j1IEdSDTM06mRyluOEGVusxZLLA1OlMTTpq_3tTplgQRHJ4Ofx4H-8DYA_BPoIQn_nJR58wsga6CAqRoJTR9cWf4URgnnbAVghjCFF8dBN0EEaYQUS6YH9wP-qpyvTysq5Nb-ZVFVwTiroKO2DDqTLY3eXcBi-XF8-D6-Tu8epmcH6XaAYZSRhxLid5pjPtKDSGodTlgiKHTcZ1GpFJTUqFyXPKI1oYzJXSAjpIkSXb4LjdO_X1e2PDTE6KoG1ZqsrWTZAcCcwyIf6FKKMpFpBGePgLjuvGV_EIiQSnLOMCR3TSIu3rELx1cuqLifJziaBclCpjqTKWGuXBcl2TT6xZuWWLERwtgQpalS6WqIuwcoQLCAWK7rR1n0Vp53_lyaf7URubtLoIM_v1o5V_kyknnMnXhys5FA-3w9GAxpBvo7KZIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>197458792</pqid></control><display><type>article</type><title>CMV and blood transfusions</title><source>Wiley</source><creator>Roback, John D.</creator><creatorcontrib>Roback, John D.</creatorcontrib><description>Among the human herpesviruses, cytomegalovirus (CMV) is the only one that has assumed significant importance in blood transfusion. Transfusion transmission of CMV (TT‐CMV) to seronegative immunocompromised patients can lead to lethal CMV disease. Studies over the past 30 years have demonstrated that monocytes latently infected with CMV represent the primary vector for TT‐CMV, and that TT‐CMV can be largely abrogated by transfusing at‐risk patients with either seronegative units or blood filtered to remove white blood cells. However, the small number of cases of breakthrough TT‐CMV that follow transfusion of either seronegative or filtered blood still produce morbidity and mortality. These circumstances have motivated ongoing efforts to provide improved protection from TT‐CMV, including the use of CMV DNA amplification for blood screening, and pathogen inactivation to sterilise all blood components prior to transfusion. Copyright © 2002 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 1052-9276</identifier><identifier>EISSN: 1099-1654</identifier><identifier>DOI: 10.1002/rmv.353</identifier><identifier>PMID: 12125013</identifier><identifier>CODEN: RMVIEW</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adult ; Biological and medical sciences ; Child ; Child, Preschool ; Cytomegalovirus - isolation &amp; purification ; Cytomegalovirus Infections - diagnosis ; Cytomegalovirus Infections - prevention &amp; control ; Cytomegalovirus Infections - transmission ; Disinfection - methods ; DNA, Viral - analysis ; Female ; Human viral diseases ; Humans ; Infant, Newborn ; Infectious diseases ; Medical sciences ; Miscellaneous ; Polymerase Chain Reaction ; Pregnancy ; Risk Factors ; Transfusion Reaction ; Viral diseases</subject><ispartof>Reviews in medical virology, 2002-07, Vol.12 (4), p.211-219</ispartof><rights>Copyright © 2002 John Wiley &amp; Sons, Ltd.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3</citedby><cites>FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13790091$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12125013$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roback, John D.</creatorcontrib><title>CMV and blood transfusions</title><title>Reviews in medical virology</title><addtitle>Rev. Med. Virol</addtitle><description>Among the human herpesviruses, cytomegalovirus (CMV) is the only one that has assumed significant importance in blood transfusion. Transfusion transmission of CMV (TT‐CMV) to seronegative immunocompromised patients can lead to lethal CMV disease. Studies over the past 30 years have demonstrated that monocytes latently infected with CMV represent the primary vector for TT‐CMV, and that TT‐CMV can be largely abrogated by transfusing at‐risk patients with either seronegative units or blood filtered to remove white blood cells. However, the small number of cases of breakthrough TT‐CMV that follow transfusion of either seronegative or filtered blood still produce morbidity and mortality. These circumstances have motivated ongoing efforts to provide improved protection from TT‐CMV, including the use of CMV DNA amplification for blood screening, and pathogen inactivation to sterilise all blood components prior to transfusion. Copyright © 2002 John Wiley &amp; Sons, Ltd.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cytomegalovirus - isolation &amp; purification</subject><subject>Cytomegalovirus Infections - diagnosis</subject><subject>Cytomegalovirus Infections - prevention &amp; control</subject><subject>Cytomegalovirus Infections - transmission</subject><subject>Disinfection - methods</subject><subject>DNA, Viral - analysis</subject><subject>Female</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Polymerase Chain Reaction</subject><subject>Pregnancy</subject><subject>Risk Factors</subject><subject>Transfusion Reaction</subject><subject>Viral diseases</subject><issn>1052-9276</issn><issn>1099-1654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqF0MlLAzEUBvAgiq0L3j1IEdSDTM06mRyluOEGVusxZLLA1OlMTTpq_3tTplgQRHJ4Ofx4H-8DYA_BPoIQn_nJR58wsga6CAqRoJTR9cWf4URgnnbAVghjCFF8dBN0EEaYQUS6YH9wP-qpyvTysq5Nb-ZVFVwTiroKO2DDqTLY3eXcBi-XF8-D6-Tu8epmcH6XaAYZSRhxLid5pjPtKDSGodTlgiKHTcZ1GpFJTUqFyXPKI1oYzJXSAjpIkSXb4LjdO_X1e2PDTE6KoG1ZqsrWTZAcCcwyIf6FKKMpFpBGePgLjuvGV_EIiQSnLOMCR3TSIu3rELx1cuqLifJziaBclCpjqTKWGuXBcl2TT6xZuWWLERwtgQpalS6WqIuwcoQLCAWK7rR1n0Vp53_lyaf7URubtLoIM_v1o5V_kyknnMnXhys5FA-3w9GAxpBvo7KZIQ</recordid><startdate>200207</startdate><enddate>200207</enddate><creator>Roback, John D.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><general>Wiley Periodicals Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200207</creationdate><title>CMV and blood transfusions</title><author>Roback, John D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cytomegalovirus - isolation &amp; purification</topic><topic>Cytomegalovirus Infections - diagnosis</topic><topic>Cytomegalovirus Infections - prevention &amp; control</topic><topic>Cytomegalovirus Infections - transmission</topic><topic>Disinfection - methods</topic><topic>DNA, Viral - analysis</topic><topic>Female</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Polymerase Chain Reaction</topic><topic>Pregnancy</topic><topic>Risk Factors</topic><topic>Transfusion Reaction</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roback, John D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Reviews in medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roback, John D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CMV and blood transfusions</atitle><jtitle>Reviews in medical virology</jtitle><addtitle>Rev. Med. Virol</addtitle><date>2002-07</date><risdate>2002</risdate><volume>12</volume><issue>4</issue><spage>211</spage><epage>219</epage><pages>211-219</pages><issn>1052-9276</issn><eissn>1099-1654</eissn><coden>RMVIEW</coden><abstract>Among the human herpesviruses, cytomegalovirus (CMV) is the only one that has assumed significant importance in blood transfusion. Transfusion transmission of CMV (TT‐CMV) to seronegative immunocompromised patients can lead to lethal CMV disease. Studies over the past 30 years have demonstrated that monocytes latently infected with CMV represent the primary vector for TT‐CMV, and that TT‐CMV can be largely abrogated by transfusing at‐risk patients with either seronegative units or blood filtered to remove white blood cells. However, the small number of cases of breakthrough TT‐CMV that follow transfusion of either seronegative or filtered blood still produce morbidity and mortality. These circumstances have motivated ongoing efforts to provide improved protection from TT‐CMV, including the use of CMV DNA amplification for blood screening, and pathogen inactivation to sterilise all blood components prior to transfusion. Copyright © 2002 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>12125013</pmid><doi>10.1002/rmv.353</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1052-9276
ispartof Reviews in medical virology, 2002-07, Vol.12 (4), p.211-219
issn 1052-9276
1099-1654
language eng
recordid cdi_proquest_miscellaneous_71925899
source Wiley
subjects Adult
Biological and medical sciences
Child
Child, Preschool
Cytomegalovirus - isolation & purification
Cytomegalovirus Infections - diagnosis
Cytomegalovirus Infections - prevention & control
Cytomegalovirus Infections - transmission
Disinfection - methods
DNA, Viral - analysis
Female
Human viral diseases
Humans
Infant, Newborn
Infectious diseases
Medical sciences
Miscellaneous
Polymerase Chain Reaction
Pregnancy
Risk Factors
Transfusion Reaction
Viral diseases
title CMV and blood transfusions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A37%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CMV%20and%20blood%20transfusions&rft.jtitle=Reviews%20in%20medical%20virology&rft.au=Roback,%20John%20D.&rft.date=2002-07&rft.volume=12&rft.issue=4&rft.spage=211&rft.epage=219&rft.pages=211-219&rft.issn=1052-9276&rft.eissn=1099-1654&rft.coden=RMVIEW&rft_id=info:doi/10.1002/rmv.353&rft_dat=%3Cproquest_cross%3E18462904%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5053-53ffb3b8c8cf40dd516fb941f2d87c6c50d6d649dbb47c8c40dd27aac90f041e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=197458792&rft_id=info:pmid/12125013&rfr_iscdi=true